Behavioural effects of norpethidine, a metabolite of pethidine, in rats

Andrews, 1942, Cortical effects of Demerol, J. Pharmacol. Exp. Ther., 76, 89 Armstrong, 1986, Normeperidine toxicity, Anesth. Analg., 65, 536, 10.1213/00000539-198605000-00024 Cantu, 1991, Central nervous system reactions to histamine-2 receptor blockers, Ann. Intern. Med., 114, 1027, 10.7326/0003-4819-114-12-1027 Eisendrath, 1987, Meperidine-induced delirium, Am. J. Psychiat., 144, 1062, 10.1176/ajp.144.8.1062 Fray, 1980, An observational method for quantifying the behavioural effects of dopamine agonists: Contrasting effects of d-amphetamine and apomorphine, Psychopharmacology, 69, 253, 10.1007/BF00433091 Hosmer, 1989 Iwamoto, 1980, Opioid-induced hypermotility in rats, 155 Kaiko, 1983, Central nervous system excitatory effects of meperidine in cancer patients, Ann. Neurol., 13, 180, 10.1002/ana.410130213 Major, 1971, Effects of α-methyl-p-tyrosine, p-chlorophenylalanine, l-β-(3,4-dihydroxyphenyl) alanine, 5-hydroxytryptophan and diethyldithiocarbonate on the analgesic activity of morphine and methylam-phetamine in the mouse, Br. J. Pharmac., 42, 512, 10.1111/j.1476-5381.1971.tb07137.x Mather, 1978, Clinical pharmacokinetics of pethidine, Clin. Pharmacokinet., 3, 352, 10.2165/00003088-197803050-00002 Mauro, 1986, Meperidine-induced seizure in a patient without renal dysfunction or sickle cell anemia, Clin. Pharm., 5, 837 Szeto, 1977, Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure or cancer, Ann. Int. Med., 86, 738, 10.7326/0003-4819-86-6-738 Umans, 1982, Antinociceptive activity and toxicity of meperidine and normeperidine in mice, J. Pharmacol. Exp. Ther., 223, 203 Waddington, 1986, Motor consequences of d-1 dopamine receptor stimulation and blockade, Clin. Neuropharmacol., 9, 20